Companion Animal Welfare

Dog Mast Cell Tumour: Welfare and Treatment Advances

How advances in mast cell tumour management are improving quality of life for affected dogs.

Key Facts

Mast cell tumours are the most common malignant skin tumour in dogs, accounting for 20-25% of skin masses
Grade and Ki67 index strongly predict behaviour - most Grade I tumours are cured by surgery alone
Toceranib (Palladia) and vinblastine provide effective systemic treatment for intermediate and high-grade disease
Quality of life assessment is central to treatment decision-making in canine oncology

Welfare Considerations

Advances in mast cell tumour grading and systemic treatment have transformed outcomes for many affected dogs. Central to welfare-conscious oncology is honest assessment of quality of life at each treatment stage, and willingness to prioritise comfort over aggressive intervention when appropriate.

What You Can Do

Have all suspicious skin lumps aspirated or removed and submitted for pathology
Discuss quality of life implications of all treatment options with your oncologist
Connect with canine cancer support groups to help navigate treatment decisions